August 11, 2025

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Unveiling a 39.75% Potential Upside in RNA-targeted Medicine

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted therapies, has captured investor attention with its robust product portfolio and a compelling potential upside of 39.75%. As a commercial-stage biotechnology..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Healthcare Giant with a Strong Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a titan in the healthcare sector, specializing in diagnostics and research. Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace provides clinical research-driven..

Penumbra, Inc. (PEN) Stock Analysis: Exploring a 29% Upside Potential in the Healthcare Sector

Penumbra, Inc. (PEN), a key player in the medical devices industry, offers a fascinating opportunity for investors with its potential upside of 29.27%. Headquartered in Alameda, California, Penumbra is recognized..

ADMA Biologics Inc (ADMA): Analyzing Its 75.91% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, offers a compelling investment opportunity with a notable potential upside of 75.91%. As a company specializing in the..

Revolution Medicines (RVMD): An Investor’s Insight into a 105.71% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector, particularly in the field of precision oncology. With a market cap of $6.54 billion, this clinical-stage company is..

Guardant Health (GH) Stock Analysis: A Promising Opportunity with 12.99% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leading player in the precision oncology sector, is capturing investor attention with its innovative diagnostic solutions and an attractive upside potential of 12.99%. As..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a Potential 22% Upside for Investors

Koninklijke Philips N.V. (NYSE: PHG), a titan in the healthcare sector, specifically in medical devices, commands significant investor attention with its current market cap of $25.51 billion. As a Netherlands-based..

DexCom, Inc. (DXCM) Investor Outlook: 29% Potential Upside with Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM) is a prominent player in the healthcare sector, specifically within the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 20.99% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors with its substantial potential upside of 20.99%, according to analyst ratings. This Utah-based company, specializing in medical instruments..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 64% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the biotechnology industry. Headquartered in Dublin, Ireland, this company is recognized..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 32.34% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors keen on the healthcare sector, specifically within the medical device industry. With a substantial market capitalization of $3.73 billion,..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unpacking a 26% Upside Potential

For investors with a keen eye on the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity. Known for its robust portfolio of over-the-counter health and personal..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a -27% Potential Downside amid Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, presents a complex investment profile that demands careful scrutiny from individual investors. Headquartered in New York, Oscar Health..

Halozyme Therapeutics, Inc. (HALO): Investor Outlook and Growth Potential with a Strong Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has carved a niche in the biotechnology sector with its innovative enzyme-based therapies, positioning itself as a formidable player in the healthcare landscape. The company’s..

Waystar Holding Corp. (WAY) Stock Analysis: 45.66% Upside Potential in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology sector, is capturing significant attention from investors with its robust potential upside of 45.66%. Founded in 2017 and..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with a 56.89% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising clinical-stage cancer therapies. Despite operating at a financial loss, the..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 29.48% Potential Upside for Biotech Investors

Bio-Techne Corp (TECH), a significant player in the biotechnology industry, presents a compelling investment opportunity for those eyeing the healthcare sector. With a market capitalization of $7.9 billion, Bio-Techne operates..

Avantor, Inc. (AVTR) Stock Analysis: A Closer Look at Its 22.76% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.84 billion, Avantor is a substantial..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Biotechnology Innovator with a 47.89% Potential Upside

Roivant Sciences Ltd. (ROIV), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and development. With a market capitalization..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Powerhouse with a 23% Upside

Investors looking to navigate the intricate world of healthcare stocks might find Danaher Corporation (NYSE: DHR) particularly enticing. With its robust presence in the diagnostics and research industry, Danaher stands..

Search

Funds

August 11, 2025

Search

Funds

August 11, 2025

FTSE 100

Funds